Matthew M. Gubin

机构：The University of Texas MD Anderson Cancer Center, Washington University in St. Louis, The University of Texas Health Science Center at Houston · ORCID：0000-0001-7443-2752

发表论文 92 篇 · 总被引 11236 次 · h-index 23

代表论文

• Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy (2024 · Cell Reports · 被引 17)
• Neoantigen Cancer Vaccines and Different Immune Checkpoint Therapies Each Utilize Both Converging and Distinct Mechanisms that in Combination Enable Synergistic Therapeutic Efficacy (2024 · SSRN Electronic Journal · 被引 3)
• Neoantigen Cancer Vaccines and Different Immune Checkpoint Therapies Each Utilize Both Converging and Distinct Mechanisms that in Combination Enable Synergistic Therapeutic Efficacy (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 3)
• AI-powered Immune Cell Knowledge Graph (ICKG) with granular immune contexts enables immune program interpretation (2026 · npj Artificial Intelligence · 被引 2)
• Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint Blockade (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 2)
• Induction of complementary immunogenic necroptosis and apoptosis cell death pathways inhibits cancer metastasis and relapse (2024 · Research Square · 被引 1)